Patent: 9,827,329
✉ Email this page to a colleague
Summary for Patent: 9,827,329
Title: | Compounds and compositions for immunotherapy |
Abstract: | Provided are compounds for targeted immunotherapy. The compounds are useful in the treatment of diseases such as cancer. Also provided are compositions comprising the compounds. |
Inventor(s): | Li; Lixin (Beijing, CN) |
Assignee: | BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) |
Application Number: | 15/110,685 |
Patent Claims: | see list of patent claims |
Details for Patent 9,827,329
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2034-01-10 |
Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | 02/19/2002 | ⤷ Try a Trial | 2034-01-10 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2034-01-10 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2034-01-10 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |